Under pressure from Donald Trump, Pfizer cuts prices on some drugs in the US
Yielding to demands from Washington, the pharmaceutical company has agreed to lower the price of medications available under public health insurance program Medicaid in exchange for a three-year exemption from tariffs.
Tomas Kauer - News Moderator
https://www.tomaskauer.com/
